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In a screen for genes with oncogenic potential ex-
pressed by the murine B6SUtA1 myeloid progenitor cell
line, we isolated a 2.5-kilobase pair cDNA whose expres-
sion causes strong morphological transformation and
deregulated proliferation of NIH 3T3 cells. The trans-
forming cDNA encodes a truncated protein (designated
Lsc) with a region of sequence similarity to the product
of the lbc oncogene. This region includes the tandemDbl
homology and pleckstrin homology domains that are
hallmarks of the Dbl-like proteins, a family of presump-
tive or demonstrated guanine nucleotide exchange fac-
tors that act on Rho family GTPases. Lsc requires intact
Dbl homology and pleckstrin homology domains for its
oncogenic activity. The transforming activity of Lsc in
NIH 3T3 cells is reduced by cotransfection with p190 (a
GTPase activating protein for Rho family GTPases) and
the Rho family dominant-negative mutants RhoA(19N),
CDC42(17N), and Rac1(17N). These results indicate a
role for the Rho family of GTPases in mediating the
transforming activity of Lsc and are consistent with the
exchange specificities that have been attributed to Dbl
family members. The lsc gene is expressed in a variety of
tissues and is particularly abundant in hemopoietic tis-
sues (thymus, spleen, and bone marrow). Lsc is a mem-
ber of a growing family of proteins that may function as
activators of Rho family GTPases in a developmental or
tissue-specific manner.
The Ras superfamily of GTPases comprises approximately
50 members, many of which have regulatory functions in trans-
ducing intracellular signals. This superfamily can be conve-
niently divided into several families (Ras, Rho/Rac, Sar, Rab,
Arf, and Ran), the members of which are related in terms of
both primary sequence and cellular activity (1–3). The Ras
family itself is involved in triggering cell proliferation via ac-
tivation of the Raf/MEK/mitogen-activated protein kinase sig-
naling pathway (4–6). Activation of members of the more di-
verse Rho/Rac family has been correlated with changes in
cytoskeletal organization (7–10) and with the transmission of
growth factor and mitogen signals to the nucleus (11–14). The
Rab, Arf, and Sar proteins regulate intracellular vesicle trans-
port, while the Ran proteins function in nuclear transport
(2, 3).
Ras-like proteins have a common intrinsic ability to bind and
hydrolyze GTP. They exert their regulatory activity by acting
as binary switches, cycling between an active GTP-bound form
and an inactive GDP-bound form (1, 15). The rate of intercon-
version of Ras proteins between these two nucleotide-bound
forms can be enzymatically modified by three families of regu-
latory molecules (2). GTPase-activating proteins (GAPs)1 in-
crease the intrinsic rate of hydrolysis of RaszGTP to RaszGDP,
an irreversible reaction that inactivates Ras-like proteins.
Guanine nucleotide dissociation inhibitors bind to and stabilize
the GDP-bound form of Rho and Rab proteins, preventing their
reactivation. Guanine nucleotide exchange factors (GEFs) ac-
celerate the release of GDP and subsequent binding of GTP and
thus serve as activators of Ras-like proteins.
GEFs have been described for virtually all the Ras GTPase
families (2). One rapidly expanding group share a 250-amino
acid stretch of significant sequence similarity with Dbl, a trans-
forming protein that was originally isolated from a diffuse B
cell lymphoma (16, 17). This domain (designated the Dbl ho-
mology or DH domain) was subsequently shown to contain GEF
activity for the Rho family of GTPases (18). Many Dbl-related
proteins, including Dbl itself, have been identified in transfor-
mation assays using NIH 3T3 cells as recipients (17, 19–23).
DH domain-containing proteins that are truncated within this
putative GEF catalytic domain consistently lose their trans-
forming activity in NIH 3T3 assays (19, 20, 24). This associa-
tion between DH domains, GEF activity, and transforming
activity in NIH 3T3 cells implicates constitutive activation of
Rho proteins as a general mechanism of transformation by
Dbl-related proteins.
In addition to Dbl, the DH family consists of CDC24 (25), Vav
(26, 27), Ect2 (23), Bcr (28), Abr (29, 30), RasGRF (31, 32), Tiam
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(33), Tim (34), Lbc (22, 35), Ost (21), FGD1 (36), Dbs (20), and
Lfc (19). CDC24, Dbl, Tiam, Ost and Lbc have been shown to
have exchange activity toward Rho family GTPases (18, 21, 35,
37, 38). The Vav protein has been reported to stimulate ex-
change activity on Ras family members but shows no activity
toward Rho/Rac GTPases (39–41). However, Vav appears to
transform fibroblasts via Ras-independent mechanisms similar
to those induced by Dbl (42, 43). Ect2 is able to bind to both Rho
and Rac but does not exhibit exchange activity for either of
these proteins (23). Although RasGRF contains a DH domain,
it is also a member of a second structurally related family of
GEFs that have activity toward Ras family members (2). The
DH domain of RasGRF does not show exchange activity for
either Ras or Rho family members (31). Two members of the
Dbl family that have not been tested for GEF function, Bcr and
Abr, have GAP activity toward Rho/Rac proteins (30, 44, 45),
but this is mediated by a domain separate from their DH
domains. The remaining members of the Dbl-related family
(Dbs, Tim, FGD1, and Lfc) have not been assayed for any
enzymatic activities.
In addition to a DH domain, Dbl family members possess a
second shared domain, the pleckstrin homology (PH) domain.
Since PH domains are found in a wide array of signaling
molecules (46) and have been implicated in both protein-pro-
tein and protein-lipid interactions, it has been suggested that
they may play a role in membrane translocation (47, 48). Dbl
family members appear to have a requirement for intact PH
domains to be transforming in NIH 3T3 assays (19, 20). Re-
placement of the PH domain of Lfc with a CAAX motif that
directs membrane localization via prenylation completely re-
stores its transforming ability (19), suggesting that PH do-
main-mediated membrane translocation may be a necessary
step for transformation by Dbl family members in NIH 3T3
cells.
In studies aimed at identifying proteins from hemopoietic
cell lines whose mis-expression can trigger deregulated cell
growth, a cDNA library constructed from the murine B6SUtA1
myeloid progenitor cell line (49) was transferred to NIH 3T3
fibroblasts and screened for growth-deregulating activity, as-
sayed by focus formation. In this study, we describe the isola-
tion and characterization of a novel transforming protein, des-
ignated Lsc, that contains the tandem DH and PH domains
that are characteristic of the Dbl family of exchange factors.
MATERIALS AND METHODS
Cell Lines—B6SUtA1 cells (49) were cultured in Dulbecco’s modified
Eagle’s medium (DMEM) containing 10% fetal bovine serum and 5
ng/ml murine interleukin-3. NIH 3T3, C3H10T1/2, and C127 cells were
obtained from American Type Culture Collection and cultured at low
density in DMEM containing either 10% calf serum (NIH 3T3) or 10%
fetal bovine serum (C3H10T1/2 and C127). The GP1E-86 (50) and
BOSC 23 (51) packaging cell lines were cultured in DMEM containing
10% calf serum and 10% fetal calf serum, respectively.
cDNA Library Construction—mRNA was prepared from B6SUtA1
cells by lysis in guanidinium isothiocyanate as described (52), followed
by binding to oligo(dT)-cellulose (53). cDNA was synthesized with ran-
dom sequence hexamers and Moloney murine leukemia virus reverse
transcriptase using methods provided by the supplier of the polymerase
(Life Technologies, Inc.). BstXI adapters (54) were added to the termini
of the double-stranded cDNA, which was then ligated with BstXI-cut
pCTV3 retroviral vector (55). Escherichia coli MC1061/p3 (54) were
transformed with the ligation mixture by electroporation and plated in
soft agar (56). Pooled plasmid DNA was purified from the transformed
bacteria by alkaline lysis (57), followed by digestion with RNase A and
RNase T1, and precipitation with ethanol.
Production of Viruses and Infection of NIH 3T3 Cells—Library plas-
mid DNA was introduced into the GP1E-86 ecotropic packaging cell
line by DEAE-dextran transfection (58). A 6-cm dish of cells at 70%
confluence was washed twice with DMEM containing 20 mM HEPES,
pH 7.2 (DMEM/H). Two ml of DMEM/H containing 2 mg/ml plasmid
DNA and 0.2 mg/ml DEAE-dextran (Mr 500,000) was then added to the
cells, followed by a 1-h incubation at 37 °C in a humidified incubator
with a 5% CO2 atmosphere. The medium was then replaced with
DMEM/H containing 10% calf serum and 0.2 mM chloroquine and the
incubation was continued for another 3 h, after which the medium was
replaced with chloroquine-free medium. At 48 h after the beginning of
the transfection, the medium was replaced with DMEM/H containing 5
mM sodium butyrate (59). The medium was collected 24 h later and
filtered. After the addition of an equal volume of fresh DMEM/H con-
taining 10% calf serum and of Polybrene to a concentration of 10 mg/ml,
the medium was added to a 10-cm dish containing 2 3 105 NIH 3T3
cells. The infecting medium was removed 18 h later, after which the
NIH 3T3 cell culture was fed at 3-day intervals with DMEM/H, 10% calf
serum.
Retroviral plasmids containing modified Lsc cDNAs were converted
into retroviruses using the BOSC 23 ecotropic virus packaging cell line
(51). All transfections were done in Falcon® six-well tissue culture
plates (Becton-Dickinson). BOSC 23 cells were plated 24–48 h prior to
transfection and were allowed to grow to 80% confluence in 2 ml of
DMEM, 10% fetal calf serum. Two hundred microliters of Hepes-buff-
ered saline solution (pH 7.05) was added to an equal volume of DNA
(1–2 mg), CaCl2 (25 mM) solution, and the resulting solution was im-
mediately added to the above medium, followed by a 12-h incubation at
37 °C in a humidified incubator with a 5% CO2 atmosphere. The me-
dium was then replaced with DMEM containing 10% fetal calf serum,
and the incubation was continued for another 12 h. The medium was
collected 12 h later and filtered. After the addition of an equal volume
of fresh DMEM containing 10% calf serum and of Polybrene to a
concentration of 10 mg/ml, the medium was added to six-well plates
containing 3 3 104 NIH 3T3 cells/well. The infecting medium was
removed 12 h later, after which the NIH 3T3 cell culture was fed at
3-day intervals with DMEM, 10% calf serum.
Recovery of cDNAs from Infected Cells—Genomic DNA was prepared
from infected NIH 3T3 cell clones by proteinase K digestion, phenol
extraction, and ethanol precipitation. 25-ml PCR reactions contained
the following components: 20 mM Tris-Cl, pH 8.75, 10 mM KCl, 10 mM
ammonium sulfate, 2 mM MgCl2, 0.1% Triton X-100, 0.1 mg/ml bovine
serum albumin, 0.2 mM each of dATP, dCTP, dGTP, and dTTP, 100 ng
each of 59 and 39 primers, 300 ng of template genomic DNA, and 1.25
units of Pfu DNA polymerase (Stratagene, La Jolla, CA). Amplification
was performed with the following thermal cycles: 95 °C for 60 s 3 1;
95 °C for 60 s, 50 °C for 30 s, 72 °C for 180 s 3 30. The amplified DNA
was extracted with phenol:chloroform (1:1), ethanol-precipitated, and
digested with MluI and BsiWI (restriction enzymes with recognition
sites that flank the cDNA within the integrated provirus). The ampli-
fied cDNAs were purified by agarose gel electrophoresis, electro-eluted
and ethanol-precipitated, and cloned by ligation into pCTV3 and trans-
formation of E. coli MC1061/p3.
Isolation of 59 Extended cDNAs—Primers matching the 59 and 39
ends of the TL27-19-1-1 cDNA were synthesized and used in conjunc-
tion with primers matching sites in the vector that flank the ends of the
cDNA insertion. PCR reactions were performed on plasmid DNA of the
cDNA library, using Pfu DNA polymerase and the cycling parameters
listed above. Amplified cDNA products were gel purified and cloned into
pBluescript KS1 (Stratagene) for sequence determination. No discrep-
ancies in sequence were found in the regions of overlap of the TL27-19-
1-1 cDNA and the various PCR products. The complete Lsc cDNA
(TL27-19-1-1 E1) was assembled by ligation of restriction enzyme-
generated fragments of the TL27-19-1-1 cDNA and the A1 PCR product.
Construction of TL27-19-1-1 Derivatives—cDNAs encoding modified
forms of the Lsc protein were generated by PCR amplification of the
TL27-19-1-1 cDNA. Descriptions of termini are provided below. Num-
bers indicate nucleotide positions in the TL27-19-1-1 cDNA. D7: 59 5
ACGCGTGTTAA fused to 86; 39 5 2429; D4: 59 5 ACGCGTCCCGG-
GAACCACCATG fused to 1091; 39 5 2429; D3: 59 5 1, 39 5 2323 fused
to TGATGAGGCGCC.
The D4 construct utilized an artificial start codon that had been
introduced by PCR, while the D3 construct contained artificial stop
codons.
PCR-directed mutagenesis was used to make the following amino
acid replacement in TL27-19-1-1: M1, tryptophan (TGG) 2336–2338 to
leucine (TTG).
All fragments that were synthesized by PCR were sequenced in their
entirety to confirm that only specified mutations had occurred.
Sequence Analysis and Comparisons—cDNA sequences were deter-
mined by a chain termination procedure using thermal cycling with
Vent thermostable polymerase (New England Biolabs). Continuous se-
quences were determined for both strands. Data base comparisons were
performed with the MPSearch program, using the Blitz server operated
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by the European Molecular Biology Laboratory (Heidelberg, Germany).
The sequence similarity analysis of Lsc and Lbc was performed with the
Bestfit program of the Genetics Computer Group (Madison, WI).
Focus Inhibition Assays—The ability of p190 GAP and dominant
negative mutants of Rac1, RhoA, and Cdc42 to modulate Lsc focus-
forming activity was determined by cotransfection focus inhibition as-
says using procedures that have been previously described for Raf
dominant negative proteins (60). Rac1(17N) and RhoA(19N) are domi-
nant negative mutations of their respective GTPases that have been
described previously (61). Wild-type p190 was kindly provided by R.
Weinberg, while the dominant negative Cdc42(17N) mutant was pro-
vided by R. Cerione. DNA transfections were done as described previ-
ously using the calcium phosphate precipitation technique (62). Briefly,
NIH 3T3 were transfected with 500 ng of pCTV3-Lsc retroviral expres-
sion vector alone, or together with 2 mg of pZip-p190, pZip-rhoA(19N),
pZip-rac1(17N), or pCMV-cdc42(17N) expression vectors. The appear-
ance of transformed foci was quantitated after 14–16 days. Transfected
cultures were stained with 0.4% crystal violet to better visualize trans-
formed foci. Relative focus-forming units were calculated based on the
number of transformed foci present in control dishes that were trans-
fected with empty vector alone. Data shown are representative of three
or more independent determinations, with each determination repre-
senting the average number of foci from four dishes.
Hybridization Analysis of RNA and DNA—Total cellular RNA,
mRNA, and genomic DNA were prepared as described above. RNA was
separated by electrophoresis through agarose gels containing 0.66 M
formaldehyde and transferred to Zeta-Probe nylon membranes (Bio-
Rad). Hybridization and high stringency washing was performed as
described (63), using DNA probes labeled with 32P by extension of
random sequence primers (64).
RESULTS
Oncogenic Selection and Recovery of the TL27-19-1-1 cDNA
Clone—We have screened a cDNA library prepared from the
B6SUtA1 myeloid progenitor cell line for clones that have
transforming activity when expressed in NIH 3T3 fibroblasts.
The B6SUtA1 library was constructed in the retroviral pCTV3
vector, converted into a library of viral clones by transient
transfection of the ecotropic packaging cell line GP1E-86, and
transferred to NIH 3T3 cells by infection. Numerous trans-
formed foci arose when the cells reached confluence. One of
these cell clones, TL27-19, was isolated, expanded, and exam-
ined by PCR for the presence of proviral inserts. Two provirus-
derived fragments of 2.7 and 2.2 kbp were amplified, consisting
of 2.4 and 1.9 kbp cDNAs, respectively, plus linked 300-bp supF
genes. These fragments were purified and recovered by inser-
tion into the retroviral vector pCTV3K using the supF gene as
a selectable marker for E. coli transformation (55). The recov-
ered cDNAs were converted to retroviral form and retested for
transforming activity in three cell lines, NIH 3T3, C3H10T1/2,
and C127. The NIH 3T3 cells infected with the 2.4-kbp cDNA
(designated TL27-19-1-1) became very refractile within 3 days
and continued to proliferate rapidly, forming large dense foci
after confluence had been reached (Fig. 1). No transforming
activity was detected in the C3H10T1/2 or C127 cell lines or in
any cell lines infected with the 1.9-kbp cDNA (data not shown).
TL27-19-1-1 Encodes a Protein With Structural Similarities
to the Dbl Family of GEFs—The complete TL27-19-1-1 cDNA
sequence has a length of 2429 bp with a single, long open
reading frame starting with an ATG codon at nucleotide 92.
This codon is in good context for translation initiation with a
purine (G) at 23 and a purine (G) at 14 (65). Although there
are no termination codons upstream of this site, the upstream
sequence is GC-rich (.80%) and therefore is unlikely to be
coding. PCR amplification of five cDNA libraries derived from
cell lines in which TL27-19-1-1 is expressed failed to extend the
cDNA at the 59 end. The open reading frame encoded by TL27-
19-1-1 contains no termination codons indicating that the
cDNA is truncated at its 39 end. Translational termination
presumably occurs at a stop codon within the flanking BstXI
linker sequence. To obtain the sequence of the complete coding
region (Fig. 2), a cDNAwith an extended 39 end (designated A1)
was isolated from an oligo(dT)-primed cDNA library derived
from the GM979 erythroleukemic cell line. The 39 terminus of
the A1 cDNA contains a poly(A) tract with a corresponding
putative polyadenylation signal and probably represents the
terminus of a full-length TL27-19-1-1 mRNA. The combined
cDNA sequence (TL27-19-1-1 E1) has a length of 3200 bp and
encodes a protein of 919 amino acids.
The TL27-19-1-1 cDNA has high sequence similarity (88%
identity) to the HIBBk30 clone (66), a partially sequenced
cDNA randomly isolated from a human infant brain cDNA
library. The high degree of identity at the nucleotide level
between these two clones argues that they are derived from
homologous human and murine genes and that the transla-
tional products have retained a highly conserved function in
these two species.
The protein encoded by the TL27-19-1-1 cDNA has structural
similarities to the Dbl family of GEFs and in particular to Lbc
and Lfc. Lbc is a Dbl family member isolated from a CML acute
phase sample (22), while Lfc was isolated from the 32D murine
myeloid cell line (19). The similarity between these three pro-
teins precisely brackets the tandem DH and PH domains. Be-
cause it is more distantly related to Lbc than is Lfc, we have
designated this new Dbl family member Lsc (Lbc’s second cous-
in). Over the 346-amino acid region of similarity between Lbc
and Lsc, 31% of the residues are identical. Five gaps need to be
inserted in the sequences to obtain this optimal alignment (Fig.
3). Over this same interval, Lsc and Lfc are 29% identical with
5 gaps inserted (data not shown). Lsc is distinguished from Lbc
by an extended N terminus (412 amino acids), and although
this region shows no significant similarities to known proteins,
it does contain the highly conserved sequence match to the
HIBBk30 human cDNA.
Domains in the Lsc Protein Required for Transformation—
The Lsc cDNA that was recovered from the original transform-
ing retrovirus is truncated downstream of the codon for Arg779.
Thus, the protein encoded by this cDNA lacks a portion of the
C terminus. NIH 3T3 cells infected with a CTV3 vector that
expresses the full-length Lsc protein (TL27-19-1-1 E1; Fig. 4)
become very refractile within 5 days and, subsequent to reach-
ing confluence, continue to proliferate rapidly forming large
dense foci. Since the transformed phenotype induced by the
expression of the full-length TL27-19-1-1 E1 cDNA is morpho-
logically indistinct from that induced by the originally isolated
and 39 truncated TL27-19-1-1 cDNA, the C terminus of the Lsc
protein is not required for, nor does it suppress, transforming
activity. Similarly, the transformed phenotype induced by the
expression of the TL27-19-1-1 cDNA (TL27-19-1-1 or D7 in Fig.
4) is morphologically indistinct from that induced by a modified
FIG. 1. Transforming activity of the TL27-19-1-1 cDNA clone.
NIH 3T3 cells were infected at low density with CTV3 retroviral vector
(A) or CTV3 carrying the TL27-19-1-1 cDNA (B). Cell cultures in 35-mm
diameter wells were stained with methylene blue 5 days after reaching
confluence.
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cDNA that initiates translation 85 amino acids upstream of the
GEF domain (D4 in Fig. 4). Thus, the unique N-terminal region
of the Lsc protein, which distinguishes it from Lbc, is also not
required for transforming activity.
A C-terminal truncation of the Lsc cDNA that removes 13 of
the C-terminal amino acids of the PH domain completely abol-
FIG. 2. Sequence of the Lsc cDNA and encoded protein. The presumed translation product, indicated in single-letter code, is shown below
the cDNA sequence. The 59 and 39 boundaries of the original TL27-19-1-1 cDNA and the overlapping cDNA (pcrA1) isolated by PCR are indicated
by arrows above the nucleotide sequence. The boundaries of the various deletions of the full-length cDNA (D3, D8, etc.) are similarly indicated. The
initiation codons for the deletions and the TL27-19-1-1 cDNA are indicated by the arrows below the translation sequence (D4 tln, etc.). The GEF
and PH domains are indicated by the single underline and dashed underline, respectively. A putative polyadenylation signal is indicated by a dotted
underline.
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ishes transformation (Fig. 4). A point mutation in the con-
served Trp749 contained within this 13-amino acid region also
abolishes the ability of Lsc to transform NIH 3T3 cells. Thus, as
is the case with other Dbl family members, the PH domain of
Lsc appears to be indispensable for transforming activity.
p190 GAP and Dominant Negative Mutants of Rac1, RhoA,
and Cdc42 Inhibit Lsc Transformation—If Lsc is transforming
through exchange activity for Rho family GTPases, we antici-
pated that blocking GTP-dependent activation of Rho family
members should impair Lsc-mediated transformation. The
p190 protein contains a C-terminal domain that has GAP ac-
tivity for several Rho family GTPases (RhoA, RhoB, Rac1,
Rac2, and Cdc42-Hs) in in vitro assays (67), and thus converts
them to the inactive, GDP-bound form. Rac1(17N), RhoA(19N),
and Cdc42(17N) are dominant-negative mutants of their re-
spective rho family GTPases (61). The equivalent mutation in
the Ras GTPase (Ras(17N)) has an enhanced affinity for GDP
and is able to block signaling by endogenous proteins, possibly
by titrating out an activating GEF (68, 69). Transformation of
NIH 3T3 cells by expression of oncogenic Vav or Dbl is blocked
when they are coexpressed with the Ras(17N) mutant (43).
Rac1(17N) and Cdc42(17N) have been previously shown to be
inhibitors of Rac1 and Cdc42 activity, respectively (70, 71).
NIH 3T3 cells were transfected with expression constructs of
Lsc, either alone or together with p190, Rac1(17N), RhoA(19N),
or Cdc42(17N) (Fig. 5). Whereas transfection with Lsc alone
caused the appearance of '65 foci/mg of transfected DNA, p190
reduces the transforming activity by approximately 10-fold ('4
foci/mg). The dominant negative mutants RhoA(19N) and
Cdc42(17N) reduced the transforming activity by 3–4-fold ('20
foci/mg), while dominant negative Rac1 reduced the transform-
ing activity by 6-fold ('10 foci/mg). Expression of the wild-type
GTPases had only slight suppressive effects on transformation
by Lsc. The incomplete inhibition observed with the dominant
negative mutations may be due in part to the incomplete trans-
fer or expression of the dominant negatives in all the cells that
acquire and express Lsc. However, it may also reflect an addi-
tive effect of activation of the different GTPases, as a combina-
tion of RhoA(19N) and Rac1(17N) suppressed transformation
by Lsc somewhat more than Rac1(17N) alone. The inhibitory
effect observed in the cotransfection with Rac1(17N) contrasts
with the inability of Rac1(17N) to inhibit focus formation when
cotransfected with RafCAAX, a engineered form of Raf kinase,
which is constitutively targeted to the plasma membrane by
the addition of a C-terminal prenylation signal (72).
Expression of the lsc Gene—A variety of hemopoietic and
non-hemopoietic cell lines were examined for expression of the
lsc gene (Fig. 6A). A probe derived from the full-length Lsc
cDNA detected a major 3.0-kb mRNA in all cell lines, albeit
with considerable variation in amount. This mRNA approxi-
mates the size of the TL27-19-1-1 E1 cDNA (3.2 kb, Fig. 2),
providing further evidence that we have identified the major
full-length Lsc cDNA. The 3.0-kb mRNA was present at rela-
tively high levels in B6SUtA1, the multipotent hemopoietic
progenitor line from which the Lsc cDNA was derived. In ad-
dition, the Lsc probe detected less abundant mRNAs in
B6SUtA1 at 4.6 and 9.0 kb. The major 3.0-kb transcript is
expressed at high levels in a variety of hemopoietic cell lines
and, to a lesser extent, in NIH 3T3 and C3H10T1/2 fibroblasts
and the breast tumor C127 cell line.
In primary murine cells, the 3.0-kb lsc mRNA was detected
at relatively high levels in hemopoietic tissues (thymus, spleen,
and bone marrow), at lower levels in kidney, at very low levels
in stomach heart and skeletal muscle and is indetectable by
Northern blot in brain or liver (Fig. 6B). In addition, this probe
detected a less abundant 5-kb mRNA, in thymus and spleen.
Structure of the lsc Gene—Restriction enzyme digestions of
genomic DNA isolated from B6SUtA1 cells and normal mouse
liver exhibited the same pattern of fragments hybridizing with
a probe derived from the Lsc cDNA (Fig. 7). Therefore, the
oncogenic B6SUtA1 cDNA does not appear to be derived from a
gene that has undergone any gross rearrangements in the
FIG. 3. Comparison of the amino acid sequences of Lsc and
Lbc. The sequences between residues 413 and 764 of Lsc and between
157 and 503 of Lbc were optimally aligned on the basis of residue
identity (vertical lines) and similarity (colons).
FIG. 4. Transforming activities of full-length, truncated, and mutated Lsc cDNAs. The domain structure of the TL27-19-1-1 encoded
protein is illustrated in the upper line, and the lines below indicate the regions of the protein included in predicted translation products of the
various truncated and mutated cDNAs. Boundaries of domains and predicted translation products are indicated with numbers referring to amino
acid positions in the full-length protein as shown in Fig. 2. The symbols on the right indicate whether the cDNA had (1) or lacked (2) transforming
activity when expressed in NIH 3T3 cells following their infection with retroviruses derived from the CTV3 vector carrying the indicated cDNA.
Expression Cloning of lsc 18647
B6SUtA1 cell line. DNA fragments hybridizing to the Lsc probe
were also observed in human genomic DNA, indicating that the
lsc gene has been conserved during the evolutionary divergence
of mice and humans. This confirms the results of the data base
comparisons, which indicate the existence of a human cDNA
homolog.
DISCUSSION
We have identified a cDNA from the murine B6SUtA1 hemo-
poietic cell line that causes strong oncogenic transformation
when expressed in NIH 3T3 fibroblasts. The novel protein that
is encoded by this cDNA (designated Lsc) contains a domain
that is characteristic of the Dbl family of GEFs. Lsc is most
closely related to the Dbl family member Lbc, an exchange
factor with specificity for Rho family GTPases (22, 35). Lsc is
distinguished from Lbc by an extended N terminus (412 amino
acids) that does not appear to be necessary for, or inhibitory to,
cellular transformation.
The oncogenic transformation of NIH 3T3 cells that is in-
duced by Lsc expression is likely to be a consequence of the
activation of one or more Rho family members via Lsc GEF
activity. Five members of the Dbl family (CDC24, Ost, Lbc, Dbl,
and Tiam) exhibit in vitro exchange activity on Rho family
GTPases (18, 21, 35, 37, 38) and activated mutants of RhoA and
Rac1 can induce morphological transformation when expressed
in NIH 3T3 cells (43, 61). In the present study, we observed
that the p190 GAP and dominant inhibitory mutants of Rac1,
RhoA, and Cdc42 blocked the transforming activity of Lsc in
NIH 3T3 cells. These observations provide support for an Lsc-
triggered activation of Rho signaling pathways and are consist-
ent with the Rho family exchange activities that have been
attributed to Dbl family GEFs. Using biochemical assays with
purified Rho family GTPases, we have determined that Lsc
promotes GDP-GTP exchange on RhoA, but not on Rac1 or
Cdc42.2 Together, these findings support a model in which
RhoA is the immediate downstream effector of Lsc transforma-
tion, with activation of Rac and Cdc42 occurring subsequently,
and contributing to transformation. Alternatively, Lsc may
2 J. A. Glaven, I. P. Whitehead, T. Nomanbhoy, R. Kay, and R.
Cerione, submitted for publication.
FIG. 5. Suppression of Lsc-mediated transformation by p190
GAP or dominant negative forms of Rac1, RhoA, or Cdc42. NIH
3T3 cells were transfected with expression constructs of Lsc alone or
together with empty vector or vector carrying p190 Rho-GAP or the
indicated wild-type or dominant negative GTPases. Foci were counted
after 14–16 days. Relative focus-forming units were calculated based on
the number of transformed foci present in control dishes that were
transfected with empty pZip-NeoSV(x)1 retrovirus vector in the absence
of Lsc. Data shown are representative of three or more independent
determinations, with each determination representing the average
number of foci from four dishes.
FIG. 6. Expression of lsc mRNAs. RNA was separated by electro-
phoresis, transferred to nylon membranes, and hybridized with 32P-
labeled TL27-19-1-1 cDNA probes. Size markers are denatured DNA
fragments of the indicated lengths that hybridize to the probe. Size
markers are provided in kilobases. Panel A, total RNA from the indi-
cated cell lines: 32D, GM979, DA-3, and B6SutA1 (myeloid cell lines);
Ba/F3 and A20 (B cell line); MBL2 (T cell line); P388D1 (macrophage cell
line); C3H10T1/2 and NIH 3T3 (fibroblast cell lines); and the C127
(breast tumor cell line). Panel B, total RNA from the indicated tissues.
Ethidium bromide-stained gels are shown below the autoradiograms to
show quantities of RNA.
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activate Rac or CDC42 independently of its function as a Rho-
specific GEF, e.g. by binding to and relocalizing these GTPases,
or other GEFs or GAPs.
Recent studies in yeast and mammalian cells have indicated
that Rho family GTPases are tightly linked in regulatory cir-
cuits and that activation of a single GTPase (e.g.. by a Rho
family GEF) can trigger a cascade of GTPase activation (re-
viewed in Ref. 73). The assembly of actin-based cytoskeletal
structures in mammalian cells involves a cascade of Rho family
GTPases, in which Cdc42 activates Rac, which in turn activates
Rho (8–10, 71). Recent studies suggest that activation of Rho
family GTPases or their associated Dbl family GEFs can me-
diate the transmission of growth factor and mitogen signals to
the nucleus via the c-Jun N-terminal kinases (JNKs; Refs. 11
and 12) through a mechanism distinct from that involved in
cytoskeletal organization (11). In addition, RhoA, Rac1, and
Cdc42 have been shown to regulate transcriptional activation
by serum response factor (SRF; Ref. 13). There are several
observations that suggest that the activation of these nuclear
signaling pathways by Rho family GTPases does not involve
the same GTPase cascade that is utilized during cytoskeletal
reorganization. First, although SRF-linked signaling is acti-
vated by RhoA, Cdc42, and Rac1, Cdc42 and Rac1 signaling is
not dependent on functional Rho (13); second, although Rac1
and Cdc42 are efficient activators of a cascade leading to JNK
and p38/Mpk2 activation, RhoA does not exhibit this activity
(12). If Lsc-mediated transformation is dependent upon multi-
ple proliferative signals to the nucleus (e.g.. through JNK
and/or SRF), it may utilize several Rho family GTPases as
immediate or secondary targets for its activity.
We have shown previously that the transforming activities of
the Dbl family members Dbs and Lfc are dependent on the
structural integrity of their respective PH domains. Disruption
of these domains, either by truncation or by point mutations,
completely abolishes transforming activity in NIH 3T3 cells
(19, 20). We have also shown that the replacement of the PH
domain of the Lfc protein with a CAAX motif that directs
membrane localization via prenylation completely restores
transforming activity, suggesting that a PH domain-dependent
recruitment of Dbl family members to the membrane may be a
necessary step for transformation of NIH 3T3 cells (19). In the
present study, we have observed that the transforming activity
of the Lsc protein in NIH 3T3 cells is also dependent upon the
structural integrity of its PH domain. This suggests that, like
Lfc, Lsc may require membrane association for its transform-
ing activity.
lscmRNAs were detected at relatively high levels in thymus,
spleen, and bone marrow as well as a variety of hemopoietic
cells, and at lower levels in some non-hemopoietic cell lines and
tissues. Unlike the related Dbl family members, lbc and lfc, lsc
expression was not detected in brain tissue. The sizes of
mRNAs hybridizing to lsc-specific probes varied among cell
lines and tissues. Although we have not determined whether
the different mRNAs detected are all derived from the lsc gene
(versus very closely related genes), under the hybridization
conditions used, such genes would have to be more closely
related to lsc than is lbc. It is more likely that the multiple
mRNAs are due to differential splicing at the lsc locus, and
these could encode variant forms of the protein that in turn
may confer some tissue specificity on the function of Lsc.
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